adinazolam mesylate
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
The pharmacokinetics and pharmacodynamics of adinazolam were studied in 15 normal, healthy, non-obse volunteers. Placebo capsules…
Alterations in brain norepinephrine (NE) have been implicated in depression, bipolar disorders, and schizophrenia. The locus…
SummaryAdinazolam, a triazolobenzodiazepine, has been studied in the treatment of depression, panic disorder and anxiety. N…
The pharmacokinetics of adinazolam and N-desmethyladinazolam (NDMAD) were studied in 14 healthy male volunteers who received 15…
The tolerance, pharmacokinetics, and pharmacodynamics of adinazolam and N‐desmethyladinazolam (NDMAD) were assessed after single…
Thirty outpatients between the ages of 60 and 85 with DSM-III Major Depression entered an 8 week randomized, double-blind…
In 72 outpatients with DSM-III major depressive episode, adinazolam was superior to placebo in all measurements. Significantly…
In 72 outpatients with DSM-III major depressive episode, adinazolam was superior to placebo in all measurements. Significantly…
A procedure for the quantitative determination of adinazolam in plasma was developed. The drug, an N-demethylated metabolite, and…